These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 15866352
1. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Surguladze S, Patel A, Kerwin RW, Knapp M, Travis MJ. Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352 [Abstract] [Full Text] [Related]
2. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation? Blin O. Encephale; 2000 Oct; 26 Spec No 1():7-11. PubMed ID: 11294060 [Abstract] [Full Text] [Related]
3. Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study. Lin CH, Wang FC, Lin SC, Huang YH, Chen CC, Lane HY. Int Clin Psychopharmacol; 2013 Sep; 28(5):267-74. PubMed ID: 23778382 [Abstract] [Full Text] [Related]
4. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis. Psarros C, Theleritis CG, Paparrigopoulos TJ, Politis AM, Papadimitriou GN. Int J Geriatr Psychiatry; 2009 May; 24(5):518-22. PubMed ID: 19072747 [Abstract] [Full Text] [Related]
5. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride. Linden M, Scheel T, Eich FX. J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647 [Abstract] [Full Text] [Related]
6. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics]. Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H. Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402 [Abstract] [Full Text] [Related]
12. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237 [Abstract] [Full Text] [Related]
14. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448 [Abstract] [Full Text] [Related]
18. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study. Herrera-Estrella M, Apiquian R, Fresan A, Sanchez-Torres I. BMC Psychiatry; 2005 May 03; 5():22. PubMed ID: 15869707 [Abstract] [Full Text] [Related]
20. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R. Acta Psychiatr Scand; 2004 Oct 03; 110(4):292-8. PubMed ID: 15352931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]